Having trouble viewing? Click to download
Treatment should focus on the underlying etiology behind these processes
Though I am primarily a cataract and refractive surgeon, I treat a lot of patients with glaucoma.
Shortcomings in ablative procedures mean that new developments in refractive surgery are welcome. Arthur Cummings, MD, FRCSEd, reviews two new technologies that will increase patient satisfaction.
Topical cenegermin has been approved by the FDA for the treatment of moderate-to-severe neurotrophic keratitis (NK), ushering in a breakthrough of management.
“The only difference between death and taxes is that death doesn’t get worse every time Congress meets.” — Will Rogers
Here's how your practice can utilize Facebook to reach out and spread the word about how you can help people with glaucoma.
Regular vision screening assessments in early childhood have been shown to reduce the risk of persistent amblyopia at 7 years of age by more than half, according to a recent retrospective record review.
Laura M. Periman, MD, shares why dry eye spurs her curiosity, and why being a “dry eye sleuth” is refreshing (yes, refreshing!) in today’s medical practice environment.